Search

everythinglearnresearchcommunity

for

Search:↓

Oxytocin receptors are found in skin cells near touch and pain neurons.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Hair transplant surgery using micropunch can cause blood vessel damage similar to vasculitis in some cases.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

New genetic discoveries may lead to better treatments for alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

GLPLS and LPP are variants of lichen planus.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Atopic dermatitis increases the risk of some autoimmune diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Common skin conditions can greatly affect a person's mental health and social life.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Type 2 diabetes slows down skin and hair renewal by blocking important stem cell activation in mice.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.